GSK · GSK plc American Depositary Shares (Each representing two
Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
Follow GSK by emailGet an email when GSK pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.
We send one confirmation email first. Only emails about GSK, unsubscribe in one click. Privacy
📣 What GSK Says Is Next
coming months · “A loss in HBsAg is associated with up to an 89% reduction in risk of liver cancer and a 62% reduction in risk of all-cause mortality. [7] This approval was accelerated by SENKU designation, granted to innovative medicines with potential to address high unmet medical need. 3 GSK continues to advance regulatory submissions for bepirovirsen across multiple geographies with decisions, including the US, expected in the coming months.”
Company press release, Aug 24, 2026 · SEC filing
in 2026 · “GSK delivers strong Q2 core results performance and continued momentum Plans announced to accelerate R&D and late-stage pipeline portfolio Expect 20+ phase III trial starts in 2026 Strong Specialty Medicines and Vaccines performance drives sales and core operating profit growth”
Company press release, Jul 28, 2026 · SEC filing
in 2026 · “If approved, they are expected to launch in 2026 with multi-blockbuster potential.”
Company press release, Jul 15, 2026 · SEC filing
Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.
Get the full GSK picture
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for GSK and every other ticker you follow. Card required, cancel anytime.
Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.